Date: 10-13 July 2019
Location: Lisbon, Portugal
Abstract deadline: 15 January 2019
In the last years, there is a great concern about the problem of bacterial resistance to antibiotics used in human medicine as well as in veterinary.
The use of antibiotics constitutes an important factor for selection of resistance, not only among pathogenic bacteria but also among the commensal ones. Antimicrobial resistance is a major problem in public health due to the possibility in therapeutic failure.
Appearance of multiresistant bacteria is probably accompanied by co-contamination of the environment, leading to a major clinical and public health concern within the lifetime of most people living today. The extensive use has heightened concerns about the expression of antimicrobial resistance, which impacts human and animal safety, food safety and environmental exposure. Antibiotic resistance is an emergent problem, and for this reason the WHO appealed for an urgent and concerted action by governments, health professionals, industry, civil society and patients to slow down the spread of drug resistance, limit its impact today and preserve medical advances for future generations. In the latest years much investigation was developed to understand the emergence of the resistance genes and their spread but this fact does not let us to control totally this problem. In this conference an attempt has been made to present the latest research on possibilities to manage this question.
The primary objective of this meeting is to bring together researchers involved in antibiotic resistance prevention and control. The meeting will take an integrated approach to research and it will bring about researchers specializing in different subjects related to antibiotic resistance. We expected to present a universal vision of the importance of antimicrobial resistance in different ecosystems and what can be done about it.
During diverse sessions, all aspects related to epidemiology of resistance in animal and zoonotic pathogens, mobile elements containing resistance genes, proteomics of antimicrobial resistance, emerging antimicrobial resistance mechanisms, control of resistant infections, antimicrobial resistance in animal pathogens and its exchange with humans, organizing antibiotic surveillance, policies to stimulate drug development and discovery and alternatives strategies to overcome the problem of antimicrobial resistance worldwide will be discussed.
Further details here